C07D 521 - Heterocyclic compounds containing unspecified hetero rings

Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
12/2004
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254376 Cyclic amidine derivative
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1395580B1 Method for the purification of triazolylmethylepoxides
12/15/2004	EP1361851A4 Primary intermediates for oxidative coloration of hair
12/15/2004	EP1359892A4 Primary intermediates for oxidative coloration of hair
12/15/2004	EP1284267B1 Triazole compounds having amide linkage
12/15/2004	EP1117639B1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
12/15/2004	EP0863755B1 Antithrombotic diamines
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/14/2004	US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/09/2004	US20040248961 Oxidation base compound has the nitrogen-based quaternary onium group; oxidation dye precursors; hair coloring with oxidizer; multi-compartment kit; chromatic, fast coloration
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483260A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	CN1552758A Preparation of sterically hindered amine ethers
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178931C Substituted pyrazole compounds
12/07/2004	US6828427 Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same
12/07/2004	US6828316 Antiallergens
12/02/2004	WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004	US20040242668 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242573 Novel compounds
12/02/2004	DE10320326A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1257542B1 Method for producing 2-(1,2,4-triazol-1-yl)-ethanols
12/01/2004	CN1551866A Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
11/2004
11/25/2004	WO2004062609A3 Pyrimidine derivatives as il-8 receptor antagonists
11/25/2004	US20040235876 4,5-Disubstituted-2-aminopyrimidines
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235793 Benzoylcyclohexenone derivatives
11/24/2004	EP1478363A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
11/24/2004	EP1109550B1 Novel nitrophenylaziridine compounds and their use as prodrugs
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	CN1549820A Activators for oligonucleotide synthesis
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/23/2004	US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004	US6822062 Supported group 8-10 transition metal olefin polymerization catalysts
11/23/2004	US6821992 Fungicides
11/18/2004	US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/11/2004	US20040225131 reacting formaldehyde with alkylamine; acidification in water, glyooxal solution; separation
11/11/2004	US20040225006 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/10/2004	EP1475370A1 Optically active azole derivative and process for producing the same
11/10/2004	EP1474422A1 R− (−) −1− 2− &lpar ;7−CHLOROBENZO i b /i THIOPHEN−3 &minus ;YL− METHOXY) −2− (2,4−DICHLOROPHENYL) −ETHYL −1 i H /i −IMID AZOLE
11/10/2004	EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
11/10/2004	EP1474405A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
11/10/2004	EP1161423B1 Thiazolyl urea derivatives and their utilization as antiviral agents
11/10/2004	CN1545501A Novel cyclohexyl sulphones
11/10/2004	CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220245 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472217A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
11/03/2004	EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/02/2004	US6812238 Water soluble fungicides for systemic mycoses; oral and parenteral administration
11/02/2004	US6812225 Pyschological disorders; antidepressants
10/2004
10/28/2004	WO2004000826A8 Processes for producing epoxytriazole derivative and intermediate therefor
10/28/2004	US20040215019 Substituted isoindoles and the e use thereof
10/28/2004	US20040214841 Quinazoline derivatives for treatment of tumours
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040211012 For example, 1-(2-(3-hydroxy-4-methyl-phenylamino)-ethyl)-3 methyl 3-H-imidazol-1-ium chloride; prepared by reacting an aminophenol with a haloacetyl chloride, reducing product with borane-tetrahydrofuran complex, reacting compound with amine
10/28/2004	US20040211011 Primary intermediates for oxidative coloration of hair
10/27/2004	EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004	CN1541214A Novel compounds
10/27/2004	CN1172931C Herbicidally active pyridine sulfonyl urea derivatives
10/27/2004	CN1172918C Isothizole derivatives useful anticancer agents
10/27/2004	CN1172892C Stabilised compositions of 0-and N-vinyl compounds and the use of ammonium salts as stabilisers
10/26/2004	US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
10/26/2004	US6809098 Compounds
10/26/2004	US6809097 Antiangiogenic and/or vascular permeability
10/21/2004	WO2004089914A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds
10/21/2004	US20040209922 Pyridine matrix metalloproteinase inhibitors
10/21/2004	US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
10/21/2004	US20040209905 Quinoline derivatives and quinazoline derivatives
10/21/2004	US20040209884 Fused azabicycic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor
10/21/2004	US20040205907 Making 2-amino-5-substituted-amino-phenol derivatives by reduction, hydrogenation, amination, hydroxylation; oxidation color dyes, hair dye mixture including coupler and developer oxidizers, yellow color shades, colorfastness
10/20/2004	EP1468999A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
10/20/2004	EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
10/20/2004	EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists
10/20/2004	CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins
10/19/2004	US6806274 Quinazoline derivatives

1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 163